Antagonism of the insulinotropic action of first generation imidazolines by openers of KATP channels

Biochemical Pharmacology

Volumn 73, Issue 1, 2007, Pages 94-102

  Wienbergen, Antje ^a   Bleck, Claudia ^a   Lackmann, Timm Grosse ^a   Rustenbeck, Ingo ^a  

^a TECHNICAL UNIVERSITY OF BRAUNSCHWEIG   (Germany)

Author keywords

B cells; Cytosolic calcium concentration; Efaroxan; Imidazolines; KATP channel; Pancreatic islets; Tolbutamide

Indexed keywords

ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATE; ALINIDINE; CALCIUM ION; DIAZOXIDE; EFAROXAN; IDAZOXAN; IMIDAZOLINE DERIVATIVE; INWARDLY RECTIFYING POTASSIUM CHANNEL SUBUNIT KIR6.2; MAGNESIUM DERIVATIVE; MAGNESIUM DILITHIUM SALT; NUCLEOSIDE DERIVATIVE; PHENTOLAMINE; POTASSIUM CHANNEL STIMULATING AGENT; QUININE; SODIUM CYANIDE; TOLBUTAMIDE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; CALCIUM CELL LEVEL; CELL MEMBRANE POTENTIAL; CONTROLLED STUDY; DEPOLARIZATION; INSULIN LIKE ACTIVITY; METABOLIC INHIBITION; MOUSE; NONHUMAN; PANCREAS ISLET CELL; PRIORITY JOURNAL; SECRETION; TISSUE SPECIFICITY;

ANIMALS; CALCIUM; DIAZOXIDE; IMIDAZOLINES; INSULIN; MEMBRANE POTENTIALS; MICE; POTASSIUM CHANNELS; TOLBUTAMIDE;

EID: 33845201305     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bcp.2006.09.017     Document Type: Article

References (42)

1. Eglen R.M., Hudson A.L., Kendall D.A., Nutt D.J., Morgan N.G., Wilson V.G., et al. Seeing through a glass darkly: casting light on imidazoline "I" sites. Trends Pharmacol Sci 19 (1998) 381-390
2. Hasselblatt A., and Schulz A. Phentolamine, a deceptive tool to investigate sympathetic nervous control of insulin release. Naunyn-Schmiedeberg's Arch Pharmacol 359 (1988) 235-242
3. Morgan N.G. Imidazoline receptors: targets for novel antihyperglycemic agents. Exp Opin Invest Drugs 8 (1999) 575-584
4. Panten U., Schwanstecher M., and Schwanstecher C. Mode of action of sulfonylureas. In: Kuhlmann J., and Puls W. (Eds). Oral antidiabetics (1996), Springer Verlag, Berlin, Heidelberg 129-159
5. Henquin J.C. A minimum of fuel is necessary for tolbutamide to mimic the effects of glucose on electrical activity in pancreatic β-cells. Endocrinology 139 (1998) 993-998
6. Ferner R.E., and Neil H.A.V. Sulphonylureas and hypoglycaemia. Br Med J 296 (1988) 949-950
7. +-channels in mouse pancreatic ß-cells. Br J Pharmacol 101 (1990) 115-120
8. ATP channels in insulin-secreting cells. Eur J Pharmacol 204 (1991) 41-48
9. + channels in pancreatic ß-cells. Br J Pharmacol 107 (1992) 8-14
10. ATP channels and interaction with the exocytotic machinery. Diabetes 45 (1996) 1610-1618
11. ATP channel-independent pathway involved in potentiation of insulin secretion by efaroxan. Diabetes 50 (2001) 340-347
12. ATP channel function. Biochem Biophys Res Commun 284 (2001) 918-922
13. ATP channel activity. Diabetes 50 (2001) 797-802
14. 2+-dependent exocytosis in pancreatix α- and β-cells. Eur J Pharmacol 466 (2003) 213-221
15. Shepherd R.M., Hashmi M.N., Kane C., Squires P.E., and Dunne M.J. Elevation of cytosolic calcium by imidazolines in mouse islets of Langerhans: implications for stimulus-response coupling of insulin release. Br J Pharmacol 119 (1996) 911-916
16. + channels in mouse pancreatic β-cells. Br J Pharmacol 104 (1991) 385-390
17. + channels in pancreatic B-cells. Exp Clin Endocrinol Diab 103 Suppl 2 (1995) 42-45
18. Rustenbeck I., Leupolt L., Kowalewski R., and Hasselblatt A. Heterogeneous characteristics of imidazoline-induced insulin secretion. Naunyn-Schmiedeberg's Arch Pharmacol 359 (1999) 235-242
19. + channel-blocking compounds. Diabetes 53 Suppl. 3 (2004) S135-S139
20. Rustenbeck I., Wienbergen A., Bleck C., and Jörns A. Desensitization of insulin secretion by depolarizing insulin secretagogues. Diabetes 53 Suppl. 3 (2004) S140-S150
21. ATP channels. Ann Rev Physiol 60 (1998) 667-687
22. + channels in health and disease. Diabetologia 42 (1999) 903-919
23. ATP channels is mediated by Kir6.2. Proc Natl Acad Sci USA 94 (1997) 11716-11720
24. Henquin J.C. Quinine and the stimulus-secretion coupling in pancreatic β-cells: glucose-like effects on potassium permeability and insulin release. Endocrinology 110 (1982) 1325-1332
25. + channels in mouse pancreatic β-cells by external tetraethylammonium and quinine. J Physiol 423 (1990) 327-342
26. Gribble F.M., Davis T.M.E., Higham C., Clark A., and Ashcroft F.M. The antimalarial agent mefloquine inhibits ATP-sensitive K-channels. Br J Pharmacol 131 (2000) 756-760
27. Grosse Lackmann T., Zünkler B.J., and Rustenbeck I. Specificity of non-adrenergic imidazoline binding sites in insulin-secreting cells and relation to the block of ATP-sensitive K+ channels. Ann NY Acad. Sci 1009 (2003) 371-377
28. Hamill O.P., Marty A., Neher E., Sakmann B., and Sigworth F.J. Improved patch-clamp techniques for high-resolution current recordings from cells and cell-free membrane patches. Pflügers Arch 391 (1981) 85-100
29. +-channels from pancreatic B-cells. FEBS Lett 239 (1988) 241-244
30. 2+ indicators with greatly improved properties. J Biol Chem 260 (1985) 3440-3450
31. ATP channels in pancreatic B-cells. Naunyn-Schmiedeberg's Arch Pharmacol 356 (1997) 410-417
32. + channel in mouse β-cells. Br J Pharmacol 111 (1994) 302-310
33. + channel currents expressed in Xenopus oocytes: a reinterpretation. J Physiol 504 (1997) 35-50
34. +-currents in isolated mouse pancreatic β-cells. FEBS Lett 261 (1990) 187-190
35. Panten U., Burgfeld J., Goerke F., Rennicke M., Schwanstecher M., Wallasch A., et al. Control of insulin secretion by sulfonylureas, meglitinide and diazoxide in relation to their binding to the sulfonylurea receptor in pancreatic islets. Biochem Pharmacol 38 (1989) 1217-1229
36. Fatherazi S., and Cook D.L. Specificity of tetraethylammonium and quinine for three K-channels in insulin-secreting cells. J Membrane Biol 120 (1991) 195-214
37. Rustenbeck I., Dickel C., and Grimmsmann T. Desensitization of insulin secretory response to imidazolines, tolbutamide and quinine. II. Electrophysiological and fluorimetric studies. Biochem Pharmacol 62 (2001) 1695-1703
38. + channels during metabolic stress in cardiac muscle. J Pharmacol Exp Ther 266 (1993) 456-467
39. + channel block by sulfonylurea in pancreatic B-cells. Am J Physiol 274 (1998) E38-E44
40. ATP channel-blocking effect of imidazolines: a comparison of the effect of efaroxan and its imidazole analogue, KU14R. Diabetologia 48 (2005) 2567-2575
41. ATP channels by binding to Kir6.2. Biochem Biophys Res Commun 251 (1998) 477-481
42. 2+ oscillations in glucose-stimulated pancreatic β-cells. Am J Physiol 276 (1999) E512-E518